We are live on ! Find out more
Castleark Management

Castleark Management Portfolio holdings

AUM $3.85B Turnover 36.91%
1-Year Est. Return 52.88%
 

CastleArk Management is an employee-owned manager of growth stock strategies, founded in 1999. It mainly buys U.S. stocks and, to a lesser extent, those of other countries, and its process aims to exploit behavioral biases found in growth stocks. Co-founder Jerome Castellini controls it and a sister firm, CastleArk Alternatives, which has existed since 2005 and sponsors private funds. Its clients are mainly investment funds and institutions, many of them retirement plans.

This Fund
S&P 500
This Quarter Est. Return
+9.03%
1 Year Est. Return
+52.88%
3 Year Est. Return
+267.53%
5 Year Est. Return
+430.36%
10 Year Est. Return
+3,639.21%
AUM
$3.14B
AUM Growth
-$67M
Cap. Flow
-$232M
Cap. Flow %
-7.39%
Top 10 Hldgs %
17.34%
Holding
430
New
63
Increased
87
Reduced
126
Closed
57
Avg Time Held
1.3 years
Top 10 Avg Time Held
0.3 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$36.9M
2
MCHP icon
Microchip Technology
MCHP
+$29.9M
3
COST icon
Costco
COST
+$24.9M
4
ABMD
Abiomed Inc
ABMD
+$23.6M
5
BIIB icon
Biogen
BIIB
+$17.5M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$33.1M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$27.6M
3
COP icon
ConocoPhillips
COP
+$26.9M
4
DVN icon
Devon Energy
DVN
+$26.3M
5
DIS icon
Walt Disney
DIS
+$25.3M

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Energy 16.35%
3 Healthcare 15.83%
4 Consumer Discretionary 13.94%
5 Industrials 13.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ULTA icon
1
Ulta Beauty
ULTA
$26.9B
$65.2M 2.08%
267,810
-22,360
-8% -$4.87M
2014 Q4
6 quarters
UNH icon
2
UnitedHealth
UNH
$299B
$58.8M 1.88%
416,450
-8,060
-2% -$1.07M
2014 Q4
6 quarters
HD icon
3
Home Depot
HD
$336B
$57M 1.82%
446,500
+16,770
+4% +$2.22M
2013 Q2
12 quarters
GE icon
4
GE Aerospace
GE
$333B
$56.3M 1.8%
373,061
-31,113
-8% -$4.54M
2015 Q4
2 quarters
CRM icon
5
Salesforce
CRM
$152B
$56M 1.79%
704,860
+23,120
+3% +$1.81M
2015 Q1
5 quarters
EW icon
6
Edwards Lifesciences
EW
$59.7B
$55.6M 1.77%
1,671,900
-158,640
-9% -$5.43M
2015 Q1
5 quarters
META icon
7
Meta Platforms (Facebook)
META
$1.53T
$51.8M 1.65%
453,045
-34,600
-7% -$3.99M
2014 Q4
6 quarters
TDG icon
8
TransDigm Group
TDG
$63.7B
$49M 1.56%
185,737
+6,490
+4% +$1.58M
2013 Q2
12 quarters
BMY icon
9
Bristol-Myers Squibb
BMY
$120B
$48M 1.53%
652,570
+76,990
+13% +$5.44M
2015 Q3
3 quarters
ADBE icon
10
Adobe
ADBE
$86.4B
$45.9M 1.46%
478,920
-39,980
-8% -$3.84M
2015 Q3
3 quarters
MNST icon
11
Monster Beverage
MNST
$86.1B
$44.7M 1.43%
3,336,900
+1,259,520
+61% +$15.2M
2015 Q3
3 quarters
AMZN icon
12
Amazon
AMZN
$2.8T
$43.4M 1.38%
1,213,400
+458,600
+61% +$15.5M
2013 Q2
12 quarters
CME icon
13
CME Group
CME
$110B
$42.9M 1.37%
440,040
-36,320
-8% -$3.43M
2013 Q2
12 quarters
EOG icon
14
EOG Resources
EOG
$77.4B
$42.5M 1.36%
509,400
-117,620
-19% -$9.42M
2013 Q2
12 quarters
DVN icon
15
Devon Energy
DVN
$47.8B
$41.2M 1.32%
1,137,840
-775,580
-41% -$26.3M
2016 Q1
1 quarter
MDT icon
16
Medtronic
MDT
$129B
$39.9M 1.27%
459,790
+456,910
+15,865% +$36.9M
2013 Q2
12 quarters
APTV icon
17
Aptiv
APTV
$7.61B
$38.2M 1.22%
610,990
+101,870
+20% +$7.12M
2016 Q1
1 quarter
PXD icon
18
DELISTED
Pioneer Natural Resources
PXD
$37.9M 1.21%
250,870
+45,500
+22% +$7.14M
2013 Q2
12 quarters
GOOG icon
19
Alphabet (Google) Class C
GOOG
$3.39T
$37.6M 1.2%
1,087,900
-685,700
-39% -$24.6M
2015 Q4
2 quarters
TPR icon
20
Tapestry
TPR
$24.2B
$36.2M 1.15%
888,725
-207,975
-19% -$8.2M
2013 Q2
12 quarters
V icon
21
Visa
V
$751B
$36M 1.15%
485,060
-40,470
-8% -$3.17M
2014 Q4
6 quarters
NXPI icon
22
NXP Semiconductors
NXPI
$64.3B
$35.7M 1.14%
456,050
-37,740
-8% -$3.24M
2014 Q1
9 quarters
CLR
23
DELISTED
Continental Resources
CLR
$35.3M 1.13%
779,900
-134,960
-15% -$5.3M
2016 Q1
1 quarter
SHW icon
24
Sherwin-Williams
SHW
$82.3B
$35.1M 1.12%
358,440
-29,760
-8% -$2.9M
2016 Q1
1 quarter
AAPL icon
25
Apple
AAPL
$5.07T
$34.4M 1.1%
1,437,800
-475,220
-25% -$11.8M
2013 Q2
12 quarters

Similar funds

Castleark Management's Q2 2016 Portfolio in Review

As of Q2 2016, Castleark Management held 430 positions worth $3.14B, down 2.1% from $3.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management withdrew a net $232M in Q2 2016, closing 57 positions and reducing 126 holdings. Its most notable exit was Nuance Communications, an estimated $16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Energy and Healthcare.

Against the trend, Castleark Management opened a new position in Biogen worth $16.1M.

  • Castleark Management's largest Q2 2016 buy was Biogen: 66,490 shares worth $16.1M.
  • Castleark Management added most to Medtronic in Q2 2016, an estimated $36.9M increase.
  • Castleark Management's biggest Q2 2016 reduction was Nike, cutting an estimated $33.1M.
  • Castleark Management fully exited Nuance Communications in Q2 2016, selling an estimated $16M.
  • Castleark Management's ten largest holdings make up 17% of its $3.14B portfolio in Q2 2016.
  • Castleark Management opened 63 new positions and closed 57 in Q2 2016.
  • Castleark Management's portfolio value fell 2.1% quarter-over-quarter to $3.14B.

Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.